إعلان
إعلان
GDTC
CytoMed Therapeutics Limited Ordinary Shares
1.31
USDبرعاية
-0.08
-5.54%
٠٨ يناير, ١٦:٠٠ UTC -5
مغلق
بعد الإغلاق
1.32
+0.01
+0.84%
تقارير أرباح GDTC
النسبة الإيجابية المفاجئة
لا توجد بيانات متاحة لسهم GDTC
%
التقرير التالي
بيانات التقرير القادم
٢٨ أبريل ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$132.60K
/-$0.04
التغير الضمني من Q2 25 (Revenue/ EPS)
--
/--
التغير الضمني من Q4 24 (Revenue/ EPS)
--
/--
CytoMed Therapeutics Limited Ordinary Shares earnings per share and revenue
On ١٤ نوفمبر ٢٠٢٥, GDTC reported earnings of -- USD per share (EPS) for Q2 25, -- the estimate of -0.04 USD, resulting in a --% surprise. Revenue reached --, compared to an expected 132.60 ألف, with a --% difference.
Looking ahead to Q4 25, 3 المحللين forecast an EPS of -0.04 USD, with revenue projected to reach 132.60 ألف USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
الأسئلة الشائعة
What were CytoMed Therapeutics Limited Ordinary Shares's earnings and revenue for the latest quarter Q2 2025?
For Q2 2025, CytoMed Therapeutics Limited Ordinary Shares reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
How did the market react to CytoMed Therapeutics Limited Ordinary Shares's Q2 2025 earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is CytoMed Therapeutics Limited Ordinary Shares expected to report next?
The next earning report is scheduled for ٢٨ أبريل ٢٠٢٦.
What are the forecasts for CytoMed Therapeutics Limited Ordinary Shares's next earnings report?
Based on 3
المحللين, CytoMed Therapeutics Limited Ordinary Shares is expected to report EPS of -$0.04 and revenue of $132.60K for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان